ArticleBlood2021

Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua.

Nisha Nair et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.